LifeMD Historical Income Statement
| LFMD Stock | USD 6.47 0.67 11.55% |
Historical analysis of LifeMD income statement accounts such as Total Revenue of 160.2 M can show how well LifeMD Inc performed in making a profits. Evaluating LifeMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of LifeMD's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining LifeMD Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LifeMD Inc is a good buy for the upcoming year.
LifeMD |
About LifeMD Income Statement Analysis
LifeMD Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to LifeMD shareholders. The income statement also shows LifeMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
LifeMD Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts LifeMD Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of LifeMD Inc minus its cost of goods sold. It is profit before LifeMD operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of LifeMD Inc. It is also known as LifeMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from LifeMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, LifeMD's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 54.3 M, whereas EBIT is forecasted to decline to (15.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 3.0M | 1.3M | 2.6M | 2.7M | Depreciation And Amortization | 868.8K | 3.8M | 6.6M | 6.9M |
LifeMD income statement Correlations
Click cells to compare fundamentals
LifeMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LifeMD income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 335.6K | 397.8K | 868.8K | 3.8M | 6.6M | 6.9M | |
| Interest Expense | 761.2K | 1.7M | 3.0M | 1.3M | 2.6M | 2.7M | |
| Selling General Administrative | 2.4M | 42.2M | 39.6M | 47.0M | 51.7M | 54.3M | |
| Total Revenue | 12.5M | 37.3M | 92.9M | 119.0M | 152.5M | 160.2M | |
| Gross Profit | 9.2M | 28.4M | 74.9M | 100.4M | 126.0M | 132.3M | |
| Other Operating Expenses | 15.4M | 95.1M | 147.2M | 158.7M | 167.0M | 175.4M | |
| Operating Income | (2.9M) | (57.8M) | (54.3M) | (39.7M) | (14.5M) | (15.2M) | |
| Ebit | (2.9M) | (57.8M) | (54.8M) | (43.4M) | (14.8M) | (15.6M) | |
| Ebitda | (2.6M) | (57.4M) | (53.9M) | (39.6M) | (8.2M) | (8.6M) | |
| Cost Of Revenue | 3.3M | 8.9M | 18.0M | 18.7M | 26.5M | 27.9M | |
| Total Operating Expenses | 12.1M | 86.2M | 129.2M | 140.1M | 148.1M | 155.5M | |
| Income Before Tax | (3.7M) | (60.4M) | (61.3M) | (44.7M) | (17.4M) | (18.3M) | |
| Total Other Income Expense Net | (761.2K) | (2.6M) | (7.0M) | (5.0M) | (2.9M) | (2.8M) | |
| Net Income | (3.5M) | (60.5M) | (61.3M) | (45.0M) | (20.6M) | (21.6M) | |
| Income Tax Expense | (122.5K) | 122.5K | 7.7K | 360.7K | 428K | 449.4K | |
| Selling And Marketing Expenses | 8.2M | 41.7M | 82.5M | 78.4M | 76.5M | 80.3M | |
| Research Development | 222.9K | 446.7K | 778.8K | 3.0M | 6.1M | 6.4M | |
| Net Income Applicable To Common Shares | (3.1M) | (63.4M) | (61.8M) | (48.6M) | (43.8M) | (41.6M) | |
| Minority Interest | (141.1K) | (2.2M) | 426.4K | 514.6K | (2.6M) | (2.5M) | |
| Net Interest Income | (761.2K) | (1.7M) | (3.0M) | (1.3M) | (2.8M) | (2.7M) | |
| Net Income From Continuing Ops | (3.5M) | (60.5M) | (61.3M) | (45.0M) | (26.2M) | (27.5M) | |
| Tax Provision | (122.5K) | 122.5K | 7.7K | 360.7K | 428K | 449.4K | |
| Reconciled Depreciation | 335.6K | 397.8K | 868.8K | 3.8M | 5.9M | 6.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 4.847 | Quarterly Revenue Growth 0.383 | Return On Assets (0.21) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.